<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Boughdad, Sarah</dc:creator>
  <dc:creator>Meyer, Marie</dc:creator>
  <dc:creator>Prior, John O.</dc:creator>
  <dc:creator>Fernandes, Victor</dc:creator>
  <dc:creator>Allenbach, Gilles</dc:creator>
  <dc:creator>Kamani, Christel</dc:creator>
  <dc:creator>Jreige, Mario</dc:creator>
  <dc:creator>Albano, Domenico</dc:creator>
  <dc:creator>Bertagna, Francesco</dc:creator>
  <dc:creator>Nicod-Lalonde, Marie</dc:creator>
  <dc:creator>Schaefer, Niklaus</dc:creator>
  <dc:creator>Treglia, Giorgio</dc:creator>
  <dc:date>2021-05-07</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">Background: Physiological focal radiopharmaceutical uptake in the head and uncinate process of the pancreas may be seen on somatostatin  receptor-based PET/CT and might lead to false-positive results for neuroendocrine tumours (NETs). We aimed to perform a systematic review  and a meta-analysis about the prevalence of this finding. Methods: We performed a comprehensive computer literature search across several  databases until July 2020. Pooled prevalence of physiological focal uptake on somatostatin receptor-based PET/CT in the pancreas was  calculated on a per-examination- based analysis and 95% confidence interval values (95% CI) were reported. Results: Six studies (684 patients  and 829 PET/CT scans) were included. The pooled prevalence of physiological uptake in the head and uncinate process of the pancreas on  somatostatin receptor-based PET/CT imaging was 34% (95% CI 19.5–48.7%) with average SUVmax values ranging from 5 to 12.6.  Heterogeneity was seen across the selected studies. Conclusions: High radiopharmaceutical uptake in the head and uncinate process of the  pancreas is frequent at somatostatin receptor-based PET/CT and it should be recognized by nuclear medicine physicians to prevent  unnecessary additional investigations. In addition, next generation PET/CT tomographs might increase the prevalence of this finding.</dc:description>
  <dc:format>application/pdf</dc:format>
  <dc:identifier>https://localhost:5000/ark:/12658/srd1319360</dc:identifier>
  <dc:identifier>https://susi.usi.ch/global/documents/319360</dc:identifier>
  <dc:identifier>https://susi.usi.ch/documents/319360/files/Treglia_cti_2021.pdf</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1007/s40336-021-00432-1</dc:relation>
  <dc:relation>info:eu-repo/semantics/altIdentifier/ark/12658/srd1319360</dc:relation>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:rights>CC BY</dc:rights>
  <dc:source>Clinical and Translational Imaging. - Springer. - 2021, vol. 9, no. 4, p. 353–360</dc:source>
  <dc:subject xmlns:ns1="xml" ns1:lang="en">Pancreas</dc:subject>
  <dc:subject xmlns:ns2="xml" ns2:lang="en">PET/CT</dc:subject>
  <dc:subject xmlns:ns3="xml" ns3:lang="en">PET</dc:subject>
  <dc:subject xmlns:ns4="xml" ns4:lang="en">Somatostatin</dc:subject>
  <dc:subject xmlns:ns5="xml" ns5:lang="en">Incidental</dc:subject>
  <dc:subject xmlns:ns6="xml" ns6:lang="en">Meta-analysis</dc:subject>
  <dc:subject xmlns:ns7="xml" ns7:lang="en">Systematic review</dc:subject>
  <dc:subject>info:eu-repo/classification/udc/61</dc:subject>
  <dc:title xmlns:ns8="xml" ns8:lang="en">Prevalence of physiological uptake in the pancreas on somatostatin receptor-based PET/CT : a systematic review and a meta-analysis</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
